Skip to main content

Advertisement

SpringerLink
Log in

Diagnostic Modalities for Squamous Cell Carcinoma: An Extensive Review of Literature-Considering Toluidine Blue as a Useful Adjunct

  • Review Paper
  • Published:
Journal of Maxillofacial and Oral Surgery Aims and scope Submit manuscript

Abstract

Introduction

Oral Squamous Cell Carcinomas have been considered as the most prevalent malignancies in the head and neck region and are frequently undiagnosed until symptomatic with an advanced stage of disease. So there is an urgent need to device methods for the detection of oral premalignant lesions and oral cancer at an early stage in order to improve the survival rate for patients. A number of tests have been done for the detection of oral cancer which include oral brush biopsy, the Vizilite, oral autofluorescence including chemiluscence, photodynamic detection, toluidine blue staining, methylene blue staining, incisional biopsy and many more.

Material

The article reviews various diagnostic modalities available at present for detection of squamous cell carcinomas and oral epithelial dysplasias based on advanced PUBMED search of the English language literature from the year 1972 to present in order to help us select the most suitable among them fulfilling the desired criteria of being non-invasive, highly specific and sensitive, economically viable, having a scope to be used for mass screening, easy to process, having low inter examiner variability and possibly not requiring high expertise to conduct and interpret the results.

Conclusion

After reviewing various diagnostic modalities, we conclude that toluidine blue staining emerges as a clear winner among all these and it can act as a valuable adjunct to incisional biopsy in detection of oral cancer and may not substitute it except in certain circumstances when its results are carefully correlated with the patient history and clinical characteristics of the mucosal disorder, considering the fact that incisional biopsy has been reported to cause dissemination of cancer cells in the circulation there by increasing the possibility of metastasis. We must emphasize that toludine blue is a screening modality and not a diagnostic procedure like biopsy and hence cannot replace a confirmatory biopsy as a whole

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Enwonwu CO, Phillips RS, Ibrahim CD, Danfillo IS (2004) Nutrition and oral health in Africa. Int Dent J 54:344–351

    PubMed  Google Scholar 

  2. Epstein JB, Zhang L, Rosin M (2002) Advances in the diagnosis of oral premalignant and malignant lesions. J Can Dent Assoc 68(10):617–621

    PubMed  Google Scholar 

  3. Gray MGL, Burls A, Elley K (2000) The clinical effectiveness of toluidine blue dye as an adjunct to oral cancer screening in general dental practice. A West Midlands Development and Evaluation Service Report. http://www.pcpoh.bham.ac.uk/publichealth/wmhtac/pdf/toludine_blue.pdf

  4. Johnson N, Franceschi S, Ferlay J, et al. (2005) Squamous cell carcinoma: tumours of the oral cavity and oropharynx (Chapter 4). In: Barnes L, Eveson JW, Reichart P, Sidransky D (eds) World Health Organization classification of tumours, pathology and genetics of head and neck tumours. Lyon: IARC publication. http://www.iarc.fr/IARCPress/pdfs/bb9/bb9-chap4.pdf.4. American Cancer Society. Facts and figures 2007. http://www.cancer.org/downloads/STT/2008CAFFfinalsecured.pdf

  5. Bettendorf O, Piffkò J, Bankfalvi A (2004) Prognostic and predictive factors in oral squamous cell cancer: important tools for planning individual therapy? Oral Oncol 40:110–119

    Article  CAS  PubMed  Google Scholar 

  6. American Cancer Society. Facts and figures 2007. http://www.cancer.org/downloads/STT/2008CAFFfinalsecured.pdf

  7. Rosenberg D, Cretin S (1989) Use of meta-analysis to evaluate tolonium chloride in oral cancer screening. Oral Surg Oral Med Oral Pathol 67:621–627

    Article  CAS  PubMed  Google Scholar 

  8. Mashberg A, Samit A (1995) Early diagnosis of asymptomatic oral and oropharyngeal squamous cancers. CA Cancer J Clin 45:328–351

    Article  CAS  PubMed  Google Scholar 

  9. Epstein JB, Oakley C, Millner A et al (1997) The utility of toluidine blue application as a diagnostic aid in patients previously treated for upper oropharyngeal carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 83:537–547

    Article  CAS  PubMed  Google Scholar 

  10. Scuibba J (1999) Improving detection of precancerous and cancerous oral lesions. J Am Dent Assoc 130:1445–1457

    Article  Google Scholar 

  11. Epstein JB, Zhang L, Poh C et al (2003) Increased allelic loss in toluidine blue positive oral malignant lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 95:45–50

  12. National Cancer Institute (2003) SEER cancer statistics review 1975–2003

  13. Tsantoulis PK, Kastrinakis NG, Tourvas AD et al (2007) Advances in the biology of oral cancer. Oral Oncol 43:523–534

    Article  CAS  PubMed  Google Scholar 

  14. Yeole BB, Ramanakumar AV, Sankaranarayanan R (2003) Survival from oral cancer in Mumbai (Bombay), India. Cancer Causes Control 14:945–952

    Article  PubMed  Google Scholar 

  15. Acha A, Ruesga MT, Rodríguez MJ, Martínez de Pancorbo MA, Aguirre JM (2005) Applications of the oral scraped (exfoliative) cytology in oral cancer and precancer. Med Oral Patol Oral Cir Bucal 10:95–102

    PubMed  Google Scholar 

  16. Moore SR, Johnson NW, Pierce AM, Wilson DF (2000) The epidemiology of mouth cancer: a review of global incidence. Oral Dis 6(2):65–74

    Article  CAS  PubMed  Google Scholar 

  17. Shafer WG, Hine MK, Levy BM (2008) Shafer’s textbook of oral pathology, 5th edn. Elsevier India, New Delhi

    Google Scholar 

  18. Su WW-Y, Yen AM-F, Chiu SY-H, Chen TH-H (2010) A community-based RCT for oral cancer screening with toluidine blue. J Dent Res 89(9):933–937

    Article  PubMed  Google Scholar 

  19. Bouquot JE, Farthing PM, Speight PM (2006) The pathology of oral cancer and precancer revisited. Curr Diag Path 12:11–21

    Article  Google Scholar 

  20. Sciubba JJ (2002) Improving detection of precancerous and cancerous oral lesions. Computer assisted analysis of the oral brush biopsy. US Collaborative OralCDx Study Group. J Am Dent Assoc 133:272

    Article  Google Scholar 

  21. Bouquot JE, Suarez P, Vigneswaran N (2010) Oral precancer and early cancer detection in the dental office—review of new technologies. J Implant Adv Clin Dent 2:47–63

    Google Scholar 

  22. Hohlweg-Majert B, Deppe H, Metzger MC, Schumm S, Hoefler H, Kesting MR, Hölzle F, Wolff KD (2009) Sensitivity and specificity of oral brush biopsy. Cancer Invest 27(3):293–297

    Article  PubMed  Google Scholar 

  23. Reddy SG, Kanala S, Chigurupat A, Kumar SR, Poosarla CS, Reddy BVR (2012) The sensitivity and specificity of computerized brush biopsy and scalpel biopsy in diagnosing oral premalignant lesions: a comparative study. J Oral Maxillofac Pathol 16(3):349–353

    Article  PubMed Central  PubMed  Google Scholar 

  24. Oral Brush Biopsy in the Early Detection of Oral Precancers and Cancers. Cytology in diagnosis oral lesions from PubMed NIH.Gov 2006

  25. Babshet M, Nandimath K, Pervatikar SK, Naikmasur VG (2011) Efficacy of oral brush cytology in the evaluation of the oral premalignant, malignant lesions. J Cytol 28(4):165–172

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  26. Kerr AR, Sirois DA, Epstein JB (2006) Clinical evaluation of chemiluminescent lighting: an adjunct for oral mucosal examinations. J Clin Dent 17:59–63

    CAS  PubMed  Google Scholar 

  27. Pierre M, Lane PM, Whitehead TGP, Zeng H et al (2006) Simple device for the direct visualization of oral-cavity. J Biomed Optics 11:024–026

    Google Scholar 

  28. Oh ES, Laskin DM (2007) Efficacy of the ViziLite system in the identification of oral lesions. J Oral Maxillofac Surg 65:424–426

    Article  PubMed  Google Scholar 

  29. Trullenque-Eriksson A, Muñoz-Corcuera M, Campo-Trapero J, Cano-Sánchez J, Bascones-Martínez A (2009) Analysis of new diagnostic methods in suspicious lesions of the oral mucosa. Med Oral Patol Oral Cir Bucal 14:210–216

    Google Scholar 

  30. Patton LL, Epstein JB, Kerr AR (2008) Adjunctive techniques for oral cancer examination and lesion diagnosis: a systematic review of the literature. J Am Dent Assoc 139:896–905

    Article  PubMed  Google Scholar 

  31. Ram S, Siar CH (2005) Chemiluminescence as a diagnostic aid in the detection of oral cancer and potentially malignant epithelial lesions. Int J Oral Maxillofac Surg 34(5):521–527

    Article  CAS  PubMed  Google Scholar 

  32. Sambandham T, Masthan KMK, Kumar MS, Jha A (2013) The application of Vizilite in oral cancer. J Clin Diagn Res 7(1):185–186

    PubMed Central  PubMed  Google Scholar 

  33. Farah CS, McCullough MJ (2007) A pilot case control study on the efficacy of acetic acid wash and chemiluminescent illumination (ViziLite™) in the visualisation of oral mucosal white lesions. Oral Oncol 43:820–824

    Article  CAS  PubMed  Google Scholar 

  34. De Veld DC, Witjes MJ, Sterenborg HJ, Roodenburg JL (2005) The status of in vivo autofluorescence spectroscopy and imaging for oral oncology. Oral Oncol 41:117–131

    Article  PubMed  Google Scholar 

  35. Roblyer D, Richards-Kortum R, Sokolov K et al (2008) Multispectral optical imaging device for in vivo detection of oral neoplasia. J Biomed Opt 13(2):024019

    Article  PubMed Central  PubMed  Google Scholar 

  36. Skala MC, Riching KM, Gendron-Fitzpatrick A, Eickhoff J, Eliceiri KW, White JG, Ramanujam N (2007) In vivo multiphoton microscopy of NADH and FAD redox states, fluorescence lifetimes, and cellular morphology in precancerous epithelia. PNAS 104:19494–19499

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  37. Roblyer D, Kurachi C, Stepanek V, Williams MD, El-Naggar AK, Lee JJ, Gillenwater AM, Richards-Kortum R (2009) Objective detection and delineation of oral neoplasia using autofluorescence imaging. Cancer Prev Res (Phila Pa) 2:423–431

    Article  Google Scholar 

  38. Poh CF, Williams PM, Zhang L, Rosin MP (2006) Heads up!—A call for dentists to screen for oral cancer. J Can Dent Assoc 72(5):413–416

    PubMed  Google Scholar 

  39. Westra WH, Sidransky D (2006) Fluorescence visualization in oral neoplasia: shedding light on an old problem. Clin Cancer Res 12(22):6594–6597

    Article  CAS  PubMed  Google Scholar 

  40. Laronde DM, Poh CF, Williams PM et al (2007) A magic wand for the community dental office? Observations from the British Columbia Oral Cancer Prevention Program. J Can Dent Assoc 73(7):607–609

    PubMed  Google Scholar 

  41. Rosin MP, Poh CF, Guillard M, Williams PM, Zhang L, MacAulay C (2007) Visualization and other emerging technologies as change makers for oral cancer prevention. Ann NY Acad Sci 1098:167–183

    Article  CAS  PubMed  Google Scholar 

  42. Williams PM, Poh CF, Hovan AJ, Ng S, Rosin MP (2008) Evaluation of a suspicious oral mucosal lesion. J Can Dent Assoc 74(3):275–280

    PubMed  Google Scholar 

  43. Rosin MP, Poh CF, Elwood JM et al (2008) New hope for an oral cancer solution: together we can make a difference. J Can Dent Assoc 74(3):261–266

    PubMed Central  PubMed  Google Scholar 

  44. Shin D, Vigneswaran N, Gillenwate A, Richards-Kortum R (2010) Advances in fluorescence imaging techniques to detect oral cancer and its precursors. Future Oncol 6(7):1143–1154

    Article  PubMed Central  PubMed  Google Scholar 

  45. Poh CF, Ng SP, Williams PM et al (2007) Direct fluorescence visualization of clinically occult high-risk oral premalignant disease using a simple hand-held device. Head Neck 29(1):71–76

    Article  PubMed  Google Scholar 

  46. Kois JC, Truelove E (2006) Detecting oral cancer: a new technique and case reports. Dent Today 25(10):94, 96–97

  47. Dwyer MO, Day A, Padgett M, Ogden GR, Mclaren S, Goodman CR (2008) Detection of mucosal abnormalities in patients with oral cancer using photodynamic technique: a pilot study. Br J Oral Maxillofac Surg 46(1):6–10

    Article  Google Scholar 

  48. Sridharan G, Shankar AA (2012) Toludine blue: a review of its chemistry and clinical utility. J Oral Maxillofac Pathol 6:251–255

    Article  Google Scholar 

  49. Lingen MW, Kalmar JR, Karrison T, Speight PM (2008) Critical evaluation of diagnostic aids for the detection of oral cancer. Oral Oncol 44:10–22

    Article  PubMed Central  PubMed  Google Scholar 

  50. Epstein JB, Scully C, Spinelli J (1992) Toluidine blue and Lugol’s iodine application in the assessment of oral malignant disease and lesions at risk of malignancy. J Oral Pathol Med 21:160–163

    Article  CAS  PubMed  Google Scholar 

  51. Lopez ML, del Valle MO, Cueto A (1994) Knowledge of the European code against cancer in sixth–form pupils and teachers in Asturias (Spain). Eur J Cancer Prev 3:207–213

    Article  CAS  PubMed  Google Scholar 

  52. Gandolfo S, Pentenero M, Broccoletti R, Pagano M, Carrozzo M, Scully C (2006) Toluidine blue uptake in potentially malignant oral lesions in vivo: clinical and histological assessment. Oral Oncol 42(1):89–95

    Article  CAS  PubMed  Google Scholar 

  53. Patton LL (2003) The effectiveness of community-based visual screening and utility of adjunctive diagnostic aids in the early detection of oral cancer. Oral Oncol 39:708–723

    Article  PubMed  Google Scholar 

  54. Missmann M, Jank Siegfried J, Laimer K, Gassner R (2006) A reason for the use of toluidine blue staining in the presurgical management of patients with oral squamous cell carcinomas. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102:741–743

    Article  PubMed  Google Scholar 

  55. Mashberg A (1983) Final evaluation of tolonium chloride rinse for screening of highrisk patients with asymptomatic squamous carcinoma. J Am Dent Assoc 106:319–323

    Article  CAS  PubMed  Google Scholar 

  56. Martin LC, Kerawala CJ, Reed M (1998) The application of toluidine blue as a diagnostic adjunct in the detection of epithelial dysplasia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85:444–446

    Article  CAS  PubMed  Google Scholar 

  57. Rodriguez PC, Lapiedra RC, Gomez GE, Martinez SL, Warnakulasuriya S (2011) The use of toludine blue in the detection of premalignant and malignant oral lesions. J Oral Pathol Med 40:300–304

    Article  Google Scholar 

  58. Guo Z, Yamaguchi K, Sanchez-Cespedes M et al (2001) Allelic losses in Ora Test-directed biopsies of patients with prior upper aerodigestive tract malignancies. Clin Cancer Res 7:1963–1968

  59. Epstein JB, Feldman R, Dolor RJ, Porter SR (2003) The utility of tolonium chloride rinse in the diagnosis of recurrent or second primary cancers in patients with prior upper aerodigestive tract cancer. Head Neck 25:911–921

    Article  PubMed  Google Scholar 

  60. Zhang L, Williams M, Poh CF et al (2005) Toluidine blue staining identifies high-risk primary oral premalignant lesions with poor outcome. Cancer Res 65:8017–8021

    CAS  PubMed  Google Scholar 

  61. Miller RL, Simms BW, Gould AR (1988) Toluidine blue staining for detection of oral premalignant lesions and carcinomas. J Oral Pathol Med 17:73–78

    Article  CAS  Google Scholar 

  62. Mashberg A (1980) Reevaluation of toluidine blue application as a diagnostic adjunct in the detection of asymptomatic oral squamous cell carcinoma: a continuing prospective study of oral cancer III. Cancer 46:758–763

    Article  CAS  PubMed  Google Scholar 

  63. Hegde CM, Kamath PN, Sridharan S, Dannana NK, Raju RM (2006) Supravital staining: its role in detecting early malignancies. Indian J Otolaryngol Head Neck Surg 58:31–34

    Google Scholar 

  64. Epstein JB, Guneri P (2009) The adjunctive role of toluidine blue in detection of oral premalignant and malignant lesions. Curr Opin Otolaryngol Head Neck Surg 17:79–87

  65. Onofre MA, Sposto MR, Navarro CM (2001) Reliability of Toluidine blue application in the detection of oral epithelial dysplasia and in situ and invasive squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 91:535–540

  66. The Oral Cancer Foundation. Early Detection, Diagnosis and Staging. The Oral Cancer Foundation site. Available at: http://www.oralcancerfoundation.org/cdc/cdc_chapter5.php

  67. Patton LL, Elter JR, Southerland JH, Strauss RP (2005) Knowledge of oral cancer risk factors and diagnostic concepts among North Carolina dentists. J Am Dent Assoc 136:602–610

  68. Siddiqui IA, Farooq MU, Siddiqui RA, RAfi SMT (2006) Role of toluidine blue in early detection of oral cancer. Pak J Med Sci 22:184–187

    Google Scholar 

  69. Chen YW, Lin JS, Wu CH, Lui MT, Kao SY, Fong Y (2007) Application of in vivo stain of methylene blue as a diagnostic aid in the early detection and screening of oral squamous cell carcinoma and precancer lesions. J Chin Med Assoc 70(11):497–503

  70. Canto MI, Setrakian S, Willis JE, Chak A, Petras RE, Sivak MV (2001) Methylene blue staining of dysplastic and nondysplastic Barrett’s esophagus: an in vivo and ex vivo study. Endoscopy 33:391–400

    Article  CAS  PubMed  Google Scholar 

  71. Canto MI, Setrakian S, Willis J, Chak A, Petras R, Powe NR, Sivak MV Jr (2000) Methylene blue-directed biopsies improve detection of intestinal metaplasia and dysplasia in Barrett’s esophagus. Gastrointest Endosc 51:560–568

    Article  CAS  PubMed  Google Scholar 

  72. Canto MI, Setrakian S, Petras RE, Blades E, Chak A, Sivak MV Jr (1996) Methylene blue selectively stains intestinal metaplasia in Barrett’s esophagus. Gastrointest Endosc 44:1–7

    Article  CAS  PubMed  Google Scholar 

  73. Suzuki S, Murakami H, Suzuki H, Sakakibara N, Endo M, Nakayama K (1979) An endoscopic staining method for detection and operation of early gastric cancer. Int Adv Surg Oncol 2:223–241

    CAS  PubMed  Google Scholar 

  74. Mufti GR, Shah PJ, Parkinson MC, Riddle PR (1990) Diagnosis of clinically occult bladder cancer by in vivo staining with methylene blue. Br J Urol 65:173–175

    Article  CAS  PubMed  Google Scholar 

  75. Gill WB, Huffman JL, Lyon ES, Bagley DH, Schoenberg HW, Straus FH 2nd (1984) Selective surface staining of bladder tumors by intravesical methylene blue with enhanced endoscopic identification. Cancer 53:2724–2727

    Article  CAS  PubMed  Google Scholar 

  76. Riaz A, Shreedhar B, Kamboj M, Riaz SN (2013) Methylene blue as an early diagnostic marker for oral precancer and cancer. Springer Plus 2:95

    Article  PubMed Central  PubMed  Google Scholar 

  77. Neville BW, Day TA (2002) Oral cancer and precancerous lesion. CA Cancer J Clin 52:195–215

    Article  PubMed  Google Scholar 

  78. Kusukawa J, Suefuji Y, Ryu F, Noguchi R, Iwamoto O, Kameyama T (2009) Dissemination of cancer cells into circulation occurs by incisional biopsy of oral squamous cell carcinoma. J Oral Pathol Med 29:303–307

    Article  Google Scholar 

  79. Dyavanagoudar S, Kale A, Bhatt K, Hallikerimath S (2008) Reverse transcriptase polymerase chain reaction study to evaluate dissemination of cancer cells into circulation after incision biopsy in oral squamous cell carcinoma. Indian J Dent Res 19(4):315–319

  80. Peters LJ (1975) A study of the influence of various diagnostic and therapeutic procedures applied to a murine squamous carcinoma on its metastatic behaviour. Br J Cancer 32:355–372

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  81. Safour IM, Wood NK, Tsiklakis K, Doemling DB, Joseph G (1984) Incisional biopsy and seeding in hamster cheek pouch carcinoma. J Dent Res 63:1116–1120

    Article  CAS  PubMed  Google Scholar 

  82. Ohtake K, Shingaki S, Nakajima T (1990) Effects of incision and irradiation on regional lymph node metastasis in carcinoma of the hamster tongue. Oral Surg Oral Med Oral Pathol 70:62–69

    Article  CAS  PubMed  Google Scholar 

  83. Eriksson O, Hagmar B, Ryd W (1984) Effects of fine-needle aspiration and other biopsy procedures on tumor dissemination in mice. Cancer 54:73–78

    Article  CAS  PubMed  Google Scholar 

  84. Kusukawa J, Kameyama T (1995) Clinical evaluation of excisional biopsy for stage I and II squamous cell carcinoma of the oral cavity. J Jpn Soc Cancer Ther 30:1817–1827

    Google Scholar 

  85. Kusukawa J, Nakamura Y, Kameyama T (1998) Evaluation of excisional biopsy for stage I and II squamous cell carcinoma of the oral cavity. Int J Clin Oncol 3:311–316

    Article  Google Scholar 

  86. Cai WM, Zhang HX, Hu YH, Gu XZ (1983) Influence of biopsy on the prognosis of nasopharyngeal carcinoma—a critical study of biopsy from the nasopharynx and cervical lymph node of 649 patients. Int J Radiol Oncol Biol Phys 9:1439–1444

    Article  CAS  Google Scholar 

  87. Gandolfo S, Carbone M, Carrozzo M, Scamuzzi S (1993) Biopsy technics in oral oncology: excisional or incisional biopsy? A crical review of the literature and the authors’ personal contribution. Minerva Stomatol 42:69–75

    CAS  PubMed  Google Scholar 

  88. Ramani P, Thomas G, Ahmed S (2005) Use of Rt-PCR in detecting disseminated cancer cells after incisional biopsy among oral squamous cell carcinoma patients. J Cancer Res Ther 1:92–97

    Article  CAS  PubMed  Google Scholar 

  89. Frydrych AM, Parsons R, Threlfall T, Austin N, Davies GR, Booth D (2010) Oral cavity squamous cell carcinoma survival by biopsy type: a cancer registry study. Aust Dent J 55:378–384

    Article  CAS  PubMed  Google Scholar 

  90. Hellman K, Hilgard P, Eccles S (1980) Metastasis: clinical and experimental aspects. Martinus Nijhoff, The Hague, pp 50–54

    Book  Google Scholar 

  91. Warnakulasuriya KA, Johnson NW (1996) Sensitivity and specificity of OraScan toludine blue mouthrinse in the detection of oral cancer and precancer. J Oral Pathol Med 25:97–103

    Article  CAS  PubMed  Google Scholar 

  92. Gupta A, Singh M, Ibrahim R, Mehrotra R (2007) Utility of toluidine blue staining and brush biopsy in precancerous and cancerous oral lesions. Acta Cytol 51(5):788–794

    Article  PubMed  Google Scholar 

  93. Wiersma AC, van der Waal I (1990) Toluidine blue staining for detection of oral squamous carcinoma. Ned Tijdschr Tandheelkd 97(10):431–432

    CAS  PubMed  Google Scholar 

  94. Silverman S Jr, Migliorati C, Barbosa J (1984) Toluidine blue staining in the detection of oral precancerous and malignant lesions. Oral Surg Oral Med Oral Pathol 57(4):379–382

    Article  PubMed  Google Scholar 

  95. Awan Kh, Yang Y, Morgan P, Warnakulasuriya S (2012) Utility of toluidine blue as a diagnostic adjunct in the detection of potentially malignant disorders of the oral cavity—a clinical and histological assessment. Oral Dis 18(8):728–733

    Article  PubMed  Google Scholar 

  96. Vahidy NA. Zaidi SHM, Jafarey NA (1972) Toluidine blue test for detection of carcinoma of the oral cavity: an evaluation. J Surg Oncol 434

  97. Allegra E, Lombardo N, Puzzo L, Garozzo A (2009) The usefulness of toluidine staining as a diagnostic tool for precancerous and cancerous oropharyngeal and oral cavity lesions. Acta Otorhinolaryngol Ital 29(4):187–190

    PubMed Central  CAS  PubMed  Google Scholar 

  98. Upadhyay J, Rao NN, Upadhyay RB, Agarwal P (2011) Reliability of toluidine blue vital staining in detection of potentially malignant oral lesions—time to reconsider. Asian Pacific J Cancer Prev 12:1757–1760

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of OMFS, D.A.V Dental College and M.M General Hospital, Yamunanagar, 135001, Haryana, India

    Naveen Chhabra, Shruti Chhabra & Nitin Sapra

Authors
  1. Naveen Chhabra
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shruti Chhabra
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nitin Sapra
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Naveen Chhabra.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chhabra, N., Chhabra, S. & Sapra, N. Diagnostic Modalities for Squamous Cell Carcinoma: An Extensive Review of Literature-Considering Toluidine Blue as a Useful Adjunct. J. Maxillofac. Oral Surg. 14, 188–200 (2015). https://doi.org/10.1007/s12663-014-0660-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12663-014-0660-6

Keywords

Search

Navigation